Clinical trials for Glial tumor
55 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGEarly Phase 1NCT07210632Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)Eben Rosenthal · PI: Patrick Kelly, MD
- RECRUITINGNCT07236840Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain TumorsTata Memorial Centre
- RECRUITINGNCT07240662Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse GliomaiOMEDICO AG
- RECRUITINGNCT07405372Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of GliomasDaping Hospital and the Research Institute of Surgery of the Third Military Medical University · PI: Xiao Chen
- RECRUITINGPhase 2NCT07110246Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade GliomasUniversity of California, San Francisco · PI: Sabine Mueller, MD, PHD
- RECRUITINGPhase 1NCT07223034A Study of 177Lu-PSMA-617 in People With GliomasMemorial Sloan Kettering Cancer Center · PI: Brandon Imber, MD
- ACTIVE NOT RECRUITINGNCT07238322[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related ChangesTelix Pharmaceuticals (Innovations) Pty Limited
- RECRUITINGN/ANCT06397560PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies TrialBaptist Health South Florida · PI: Robert Press, M.D.
- RECRUITINGEarly Phase 1NCT06610682Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With PlixorafenibSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Karisa Schreck, MD
- RECRUITINGPhase 1NCT06773481BC008-1A Injection for Recurrent CNS WHO G4 GliomaSichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
- RECRUITINGPhase 2NCT06801730Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent GliomaZhifeng Tian,MD · PI: Zhifeng Tian
- RECRUITINGPhase 1NCT05460507Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL TreatmentPlus Therapeutics · PI: Andrew J Brenner, PhD
- RECRUITINGNCT06546631Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma PatientsUniversity College Cork
- RECRUITINGEarly Phase 1NCT0555304118F-Fluciclovine PET-MRI in High-grade GliomaChildren's Hospital of Philadelphia · PI: Mariam Aboian, MD,PhD
- RECRUITINGNCT06180434Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 GliomasErasmus Medical Center · PI: Alejandra Mendez Romero, MD PhD
- RECRUITINGPhase 3NCT06330337Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade GliomaThe Third Affiliated hospital of Zhejiang Chinese Medical University
- RECRUITINGN/ANCT06381726Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of LifeUniversity of Milan · PI: Lorenzo Bello, MD
- RECRUITINGNCT06036381Spatial and Temporal Characterization of Gliomas Using Radiomic AnalysisTata Memorial Centre · PI: Dr. ARCHYA DASGUPTA, MD
- RECRUITINGPHASE1, PHASE2NCT06161519PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsNational Cancer Institute (NCI) · PI: Jing Wu, M.D.
- RECRUITINGPHASE1, PHASE2NCT06011109Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and BevacizumabAveta Biomics, Inc. · PI: Nicole Shonka, MD
- RECRUITINGNCT06620055Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas GliomasCentro di Riferimento Oncologico - Aviano · PI: Giuseppe Toffoli
- RECRUITINGPhase 2NCT05964569Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade GliomaUniversity Hospital Heidelberg
- RECRUITINGNCT06043232MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for GliomasHuashan Hospital
- RECRUITINGNCT06138340The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial GliomaBeijing Tiantan Hospital
- RECRUITINGNCT05386043Registering Genomics and Imaging of Tumors (ReGIT)Indiana University · PI: Jason Parker, PhD
- RECRUITINGPhase 3NCT05512403Evaluation of Diagnostic Performances of 18F-FDOPA PET KIneticsCentral Hospital, Nancy, France · PI: Antoine VERGER, MD, PhD
- RECRUITINGPhase 3NCT05303519SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Nuvation Bio Inc.
- RECRUITINGEarly Phase 1NCT05773326Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGGNader Sanai · PI: Nader Sanai, MD
- RECRUITINGNCT05259605Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationEuropean Organisation for Research and Treatment of Cancer - EORTC · PI: Michael Weller
- RECRUITINGNCT06883214Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical ApplicationRegina Elena Cancer Institute
- RECRUITINGPhase 1NCT05686798Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.Henry Ford Health System · PI: Tobias Walbert, MD, PhD
- RECRUITINGPhase 2NCT05345002All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaStephen Bagley, MD, MSCE · PI: Stephen Bagley, MD MSCE
- RECRUITINGN/ANCT05049148Platelets Activation in Brain NeoplasmsFondation Ophtalmologique Adolphe de Rothschild · PI: Pierre BOURDILLON, MD
- ACTIVE NOT RECRUITINGN/ANCT05511324Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma PatientsM.D. Anderson Cancer Center · PI: Kathryn Milbury, MA,PHD
- RECRUITINGNCT05489783Glioma Developmental and HyperActive Ras Tumor (DHART) BoardMemorial Sloan Kettering Cancer Center · PI: Anna Piotrowski
- RECRUITINGNCT05859659Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)Yaou Liu · PI: Yaou Liu, Doctor
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05047913Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MRM.D. Anderson Cancer Center · PI: Caroline Chung
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05045027Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent GliomaJonsson Comprehensive Cancer Center · PI: Benjamin M Ellingson
- ENROLLING BY INVITATIONN/ANCT04063514The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain BarrierNeurological Associates of West Los Angeles · PI: Sheldon Jordan, M.D.
- RECRUITINGEarly Phase 1NCT04943913Study of GC101 TIL in Brain Glioma (Soochow2)Shanghai Juncell Therapeutics · PI: Qing Lan
- RECRUITINGN/ANCT04699773LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)University of Maryland, Baltimore
- ACTIVE NOT RECRUITINGN/ANCT04186832Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation TherapyM.D. Anderson Cancer Center · PI: Shiao-Pei S Weathers
- RECRUITINGNCT04975139Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State NetworksWashington University School of Medicine · PI: Jiayi Huang, M.D.
- RECRUITINGN/ANCT04373720MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated GliomasM.D. Anderson Cancer Center · PI: Melissa Chen, MD
- RECRUITINGPhase 2NCT03991832Study of Olaparib and Durvalumab in IDH-Mutated Solid TumorsUniversity Health Network, Toronto · PI: Eric Chen, M.D.
- RECRUITINGN/ANCT03761121Developing Fast Pediatric ImagingBoston Children's Hospital · PI: Kawin Setsompop, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT03718767Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator PhenotypeNational Cancer Institute (NCI) · PI: Jing Wu, M.D.
- RECRUITINGN/ANCT03684109Non-invasive Glioma Characterization Through Molecular ImagingUniversity of Miami · PI: Macarena De La Fuente, MD
- ACTIVE NOT RECRUITINGPhase 1NCT03514069Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaCase Comprehensive Cancer Center · PI: David Peereboom, MD
- RECRUITINGPhase 4NCT03048084Seizure Treatment in GliomaLeiden University Medical Center
- ACTIVE NOT RECRUITINGPhase 1NCT03030066Study of DS-1001b in Patients With Gene IDH1-Mutated GliomasDaiichi Sankyo · PI: Global Clinical Leader
- RECRUITINGPHASE1, PHASE2NCT01906385Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)Plus Therapeutics · PI: Andrew J Brenner, PhD
- RECRUITINGNCT01772771Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramM.D. Anderson Cancer Center · PI: Funda Meric-Bernstam
- ACTIVE NOT RECRUITINGN/ANCT01473485ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain TumorsInSightec
- RECRUITINGN/ANCT00870129Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsMemorial Sloan Kettering Cancer Center · PI: Robert Young, MD